Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Sci Transl Med. 2011 Nov 16;3(109):109ps45. doi: 10.1126/scitranslmed.3003390.

Targeting chaperone-mediated autophagy in cancer.

Author information

  • 1Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA.

Abstract

A study in this issue of Science Translational Medicine provides fresh insight into the role of autophagy in cancer. Kon et al. show that a specific type of autophagy, called chaperone-mediated autophagy (CMA), is consistently elevated in tumors and is required for optimal tumor growth and metastasis. Selective inhibition of CMA slows tumor growth, boosts tumor cell death, and induces the regression of existing tumors. This work provides a rationale for further exploring manipulation of the CMA pathway as a strategy for treating cancer.

Comment on

PMID:
22089450
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk